Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 21:13:1029146.
doi: 10.3389/fmicb.2022.1029146. eCollection 2022.

Outer membrane vesicles: A bacterial-derived vaccination system

Affiliations
Review

Outer membrane vesicles: A bacterial-derived vaccination system

Linda A Lieberman. Front Microbiol. .

Abstract

Outer membrane vesicles (OMVs) are non-living spherical nanostructures that derive from the cell envelope of Gram-negative bacteria. OMVs are important in bacterial pathogenesis, cell-to-cell communication, horizontal gene transfer, quorum sensing, and in maintaining bacterial fitness. These structures can be modified to express antigens of interest using glycoengineering and genetic or chemical modification. The resulting OMVs can be used to immunize individuals against the expressed homo- or heterologous antigens. Additionally, cargo can be loaded into OMVs and they could be used as a drug delivery system. OMVs are inherently immunogenic due to proteins and glycans found on Gram negative bacterial outer membranes. This review focuses on OMV manipulation to increase vesiculation and decrease antigenicity, their utility as vaccines, and novel engineering approaches to extend their application.

Keywords: bacteria; glycoengineering; lipopolysaccharide; outer membrane vesicle; vaccine.

PubMed Disclaimer

Conflict of interest statement

LL was employed by Merck & Co., Inc.

Figures

FIGURE 1
FIGURE 1
Schematic drawing of outer membrane vesiculation from a gram negative bacterial cell wall.
FIGURE 2
FIGURE 2
Gram negative cell membrane structure. Selected proteins manipulated in outer membrane vesicle (OMV) engineering are shown. Lipopolysaccharide (LPS) substructures are highlighted.

References

    1. Arnold R., Galloway Y., McNicholas A., O’Hallahan J. (2011). Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand. Vaccine 29 7100–7106. 10.1016/j.vaccine.2011.06.120 - DOI - PubMed
    1. Avila-Calderón E. D., Ruiz-Palma M. S., Aguilera-Arreola M. G., Velázquez-Guadarrama N., Ruiz E. A., Gomez-Lunar Z., et al. (2021). Outer membrane vesicles of Gram-negative bacteria: An outlook on biogenesis. Front. Microbiol. 12:345. 10.3389/fmicb.2021.557902 - DOI - PMC - PubMed
    1. Balhuizen M. D., Veldhuizen E. J. A., Haagsman H. P. (2021). Outer membrane vesicle induction and isolation for vaccine development. Front. Microbiol. 12:629090. 10.3389/fmicb.2021.629090 - DOI - PMC - PubMed
    1. Bernadac A., Gavioli M., Lazzaroni J. C., Raina S., Lloubès R. (1998). Escherichia coli tol-pal mutants form outer membrane vesicles. J. Bacteriol. 180 4872–4878. 10.1128/JB.180.18.4872-4878.1998 - DOI - PMC - PubMed
    1. Bottero D., Gaillard M. E., Zurita E., Moreno G., Martinez D. S., Bartel E., et al. (2016). Characterization of the immune response induced by pertussis OMVs-based vaccine. Vaccine 34 3303–3309. 10.1016/j.vaccine.2016.04.079 - DOI - PubMed

LinkOut - more resources